We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

ALCOR Scientific Inc.

ALCOR Scientific develops and manufactures proprietary devices for the clinical diagnostics and enteral feeding devic... read more Featured Products: More products

Download Mobile App




Availability Expanded for CE-Marked Erythrocyte Sedimentation Rate Analyzer

By LabMedica International staff writers
Posted on 13 Aug 2014
An advanced technology erythrocyte sedimentation rate (ESR) analyzer, that delivers results in seconds using small sample, is now available globally.

ALCOR Scientific, Inc. More...
(Smithfield, RI, USA), provider of in vitro diagnostic analyzers and devices for enteral nutrition delivery, has expanded availability of its iSED system for ESR testing to meet growing demand for this advanced technology. Designed, manufactured, and initially launched late 2012 in the USA, the iSED is CE-marked and now available globally, through distributors in Europe, Asia, Africa, South America and North America.

iSED provides accurate, efficient, automated ESR testing – one of the most widely used lab tests worldwide, yet historically one of the most time-consuming and cumbersome to perform. It transforms ESR testing by employing patented technology that delivers accurate results in 20 seconds using a blood sample of just 100 µL, especially important in working with pediatric and geriatric patients. The iSED has a throughput of up to 180 samples per hour, made possible by its random access, continuous feed operation. The system tests samples directly from standard EDTA tubes, reducing both testing costs and contaminated waste. With its closed tube sampling and no disposables required, the iSED greatly speeds processes and improves efficiency, as well as safety for lab clinicians.

The iSED’s high degree of accuracy is enabled by the use of quantitative photometry to measure, in a controlled environment, the formation of the red cell aggregates (Rouleaux) in the most critical phase of the red cell sedimentation. This technology ensures that results obtained, unaffected by variables such as mixing and temperature, accurately reflect the patient’s inflammation status.

“The iSED’s rapid adoption is a testament to its ability to facilitate patient testing through a cost-effective and user-friendly solution that streamlines lab processes,” said Carlo Ruggeri, ALCOR CEO and founder, “Alcor looks forward to introducing new, innovative diagnostic and medical device products driven by the same principles.”

The iSED was recently featured at the American Association of Clinical Chemistry (AACC) Annual Meeting and Expo in Chicago (IL, USA), July 29–31, 2014.

Related Links:

ALCOR Scientific



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Automatic CLIA Analyzer
Shine i6000
Gold Member
POCT RT-qPCR Analyzer
BG-X6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.